Clinical and genomic signatures of rising SARS-CoV-2 Delta breakthrough infections in New York
View ORCID ProfileRalf Duerr, Dacia Dimartino, Christian Marier, Paul Zappile, Samuel Levine, Fritz François, Eduardo Iturrate, Guiqing Wang, Meike Dittmann, Jennifer Lighter, Brian Elbel, Andrea B. Troxel, Keith S. Goldfeld, Adriana Heguy
doi: https://doi.org/10.1101/2021.12.07.21267431
Ralf Duerr
1Department of Microbiology, NYU Grossman School of Medicine
Dacia Dimartino
2Genome Technology Center, Office of Science and Research, NYU Langone Health
Christian Marier
2Genome Technology Center, Office of Science and Research, NYU Langone Health
Paul Zappile
2Genome Technology Center, Office of Science and Research, NYU Langone Health
Samuel Levine
3Hospital Operations, NYU Langone Health
Fritz François
4Department of Medicine, NYU Grossman School of Medicine
Eduardo Iturrate
4Department of Medicine, NYU Grossman School of Medicine
Guiqing Wang
5Department of Pathology, NYU Grossman School of Medicine
Meike Dittmann
1Department of Microbiology, NYU Grossman School of Medicine
Jennifer Lighter
6Department of Pediatric Infectious Diseases, NYU Grossman School of Medicine
Brian Elbel
7Department of Population Health, NYU Grossman School of Medicine
8NYU Wagner Graduate School of Public Service
Andrea B. Troxel
7Department of Population Health, NYU Grossman School of Medicine
Keith S. Goldfeld
7Department of Population Health, NYU Grossman School of Medicine
Adriana Heguy
2Genome Technology Center, Office of Science and Research, NYU Langone Health
5Department of Pathology, NYU Grossman School of Medicine
Posted December 17, 2021.
Clinical and genomic signatures of rising SARS-CoV-2 Delta breakthrough infections in New York
Ralf Duerr, Dacia Dimartino, Christian Marier, Paul Zappile, Samuel Levine, Fritz François, Eduardo Iturrate, Guiqing Wang, Meike Dittmann, Jennifer Lighter, Brian Elbel, Andrea B. Troxel, Keith S. Goldfeld, Adriana Heguy
medRxiv 2021.12.07.21267431; doi: https://doi.org/10.1101/2021.12.07.21267431
Clinical and genomic signatures of rising SARS-CoV-2 Delta breakthrough infections in New York
Ralf Duerr, Dacia Dimartino, Christian Marier, Paul Zappile, Samuel Levine, Fritz François, Eduardo Iturrate, Guiqing Wang, Meike Dittmann, Jennifer Lighter, Brian Elbel, Andrea B. Troxel, Keith S. Goldfeld, Adriana Heguy
medRxiv 2021.12.07.21267431; doi: https://doi.org/10.1101/2021.12.07.21267431
Subject Area
Subject Areas
- Addiction Medicine (368)
- Allergy and Immunology (689)
- Anesthesia (184)
- Cardiovascular Medicine (2742)
- Dermatology (234)
- Emergency Medicine (413)
- Epidemiology (12391)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4256)
- Geriatric Medicine (394)
- Health Economics (699)
- Health Informatics (2751)
- Health Policy (1018)
- Hematology (369)
- HIV/AIDS (879)
- Medical Education (404)
- Medical Ethics (111)
- Nephrology (451)
- Neurology (4030)
- Nursing (216)
- Nutrition (598)
- Oncology (2125)
- Ophthalmology (604)
- Orthopedics (251)
- Otolaryngology (312)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (478)
- Pediatrics (1147)
- Primary Care Research (466)
- Public and Global Health (6647)
- Radiology and Imaging (1446)
- Respiratory Medicine (886)
- Rheumatology (420)
- Sports Medicine (352)
- Surgery (464)
- Toxicology (57)
- Transplantation (192)
- Urology (171)